Lymph node ratio as a predictor of survival in gastric carcinoma

20Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

According to the American Joint Committee on Cancer (AJCC), the number of metastatic lymph nodes is the main prognostic factor in gastric cancer. Lymph node ratio (LNR) has been proposed as a better predictor of survival. We included patients resected for gastric cancer in a referral center in Mexico City. Number of metastatic nodes was analyzed according to AJCC 2002 and 2010. We divided LNR into four stages. Survival was calculated with the Kaplan-Meier method and curves compared with the log-rank test. P < 0.05 was significant. Two hundred patients were included. Median number of retrieved and metastatic nodes were 18 and 2.5, respectively. Median survival was 44 months. AJCC 2010 was a better predictor of survival than the 2002 version (P < 0.001). Median survival for LNR 0, 1, 2, and 3 was 117, 68, 44, and 14 months, respectively (P < 0.001). In patients with less than 15 nodes removed, AJCC was not a predictor of survival (P = 0.09) but LNR was (P = 0.04). Nodal staging in AJCC 2010 is a better predictor of survival than the 2002 edition. LNR is useful in the group of patients with suboptimal node dissection.

Cite

CITATION STYLE

APA

Medina-Franco, H., Cabrera-Mendoza, F., Almaguer-Rosales, S., Guillén, F., Suárez-Bobadilla, Y. L., & Sánchez-Ramón, A. (2013). Lymph node ratio as a predictor of survival in gastric carcinoma. American Surgeon, 79(3), 284–289. https://doi.org/10.1177/000313481307900328

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free